Anzeige
Meldung des Tages: Early Bird Special: Ad-hoc im Schatten einer milliardenschweren Entscheidung

Meiragtx Holdings News

Aktie
WKN:  A2JGHF ISIN:  KYG596651029 US-Symbol:  MGTX Branche:  Biotechnologie Land:  USA
8,025 €
+0,00 €
0,00%
16:36:34 Uhr
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
15,19%
KGV
-3,51
Index-Zuordnung
-

Meiragtx Holdings News

03.02.26 - PR Newswire
ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy
ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-​in-Class AAV Gene Therapy for Geographic Atrophy PR Newswire
20.11.25 - PR Newswire
Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx Conference
Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx Conference PR Newswire
24.11.24 - PR Newswire
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-​Executive Directors PR Newswire
21.12.23 - PR Newswire
Thinking about buying stock in Hookipa Pharma, Riot Platforms, Celestica, Mesoblast, or MeiraGTx?
Thinking about buying stock in Hookipa Pharma, Riot Platforms, Celestica, Mesoblast, or MeiraGTx? PR Newswire
31.10.23 - PR Newswire
Thinking about buying stock in T2 Biosystems, Cybin, Alphabet Inc, Archer Aviation, or MeiraGTx Holdings?
Thinking about buying stock in T2 Biosystems, Cybin, Alphabet Inc, Archer Aviation, or MeiraGTx Holdings? PR Newswire
28.09.21 - GlobeNewswire
MeiraGTx to Present at the Chardan 5th Annual Genetic Medicines Conference
LONDON and NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today ...
09.09.21 - GlobeNewswire
MeiraGTx Announces Data at EURETINA 2021 Virtual Meeting Demonstrating Reversal of Disease Progression Following Treatment with AAV5-RPGR in X-Linked Retinitis Pigmentosa
LONDON and NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today ...
11.08.21 - GlobeNewswire
MeiraGTx Reports Second Quarter 2021 Financial and Operational Results
LONDON and NEW YORK, Aug. 11, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today ...
11.05.21 - GlobeNewswire
MeiraGTx Reports First Quarter 2021 Financial and Operational Results
LONDON and NEW YORK, May 11, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today ...
05.05.21 - GlobeNewswire
MeiraGTx Announces Participation at Upcoming Investor Conferences
LONDON and NEW YORK, May 05, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today ...
19.04.21 - GlobeNewswire
MeiraGTx to Present at Chardan 5th Annual Genetic Medicines Manufacturing Summit
LONDON and NEW YORK, April 19, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today ...
11.03.21 - GlobeNewswire
MeiraGTx Reports Fourth Quarter and Full Year 2020 Financial and Operational Results
-  Preparing to Initiate Phase 3 Lumeos Clinical Trial in AAV-RPGR -  Announced Positive Preliminary Clinical Data from AQUAx AAV-hAQP1 Phase 1 Trial for Treatment of Grade 2/3 ...
26.01.21 - GlobeNewswire
MeiraGTx Announces AAV-CNGA3 Granted Fast Track Designation by U.S. FDA for Treatment of Achromatopsia
LONDON and NEW YORK, Jan. 26, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings Plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today ...
16.12.20 - GlobeNewswire
MeiraGTx To Present Clinical Program Update for AAV-hAQP1 Treatment of Radiation-Induced Xerostomia
Webcast and conference call to take place on December 17, 2020 at 8:00 a.m. ET
30.11.20 - GlobeNewswire
MeiraGTx to Participate in the Evercore ISI 3rd Annual HealthCONx Conference
LONDON and NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today ...
23.11.20 - GlobeNewswire
MeiraGTx to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
LONDON and NEW YORK, Nov. 23, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today ...
19.11.20 - GlobeNewswire
MeiraGTx Announces Pricing of Public Offering of Ordinary Shares
LONDON and NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq:MGTX), a vertically integrated, clinical stage gene therapy company, today ...
18.11.20 - GlobeNewswire
MeiraGTx Announces Proposed Public Offering of Ordinary Shares
LONDON and NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today ...
13.11.20 - GlobeNewswire
MeiraGTx Announces Investigational Gene Therapy Continues to Demonstrate Statistically Significant Improvement in Vision in Patients with X-Linked Retinitis Pigmentosa One Year After Treatment
Data presented at AAO 2020 Virtual Annual Meeting show sustained improvements in retinal sensitivity at 12 months
10.11.20 - GlobeNewswire
MeiraGTx to Present at the Barclays Gene Editing & Gene Therapy Summit
LONDON and NEW YORK, Nov. 10, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today ...

Newssuche

Videos

newspaper
26.04.26
Big Fish Strategy Einführung
Strategie-​Paket inklusive Live-​Webinar am 3.5., Videoaufzeichnung, Unterlagen und Nachbetreuung JETZT ... Mehr »
Anzeige

Aktie im Fokus

Mit Graphen gegen jede Abwehr
Plaid Technologies
0,396 €
+7,03%
Plaid Technologies Chart
Die Zukunft der Drohnen ist da
Mehr zur Aktie »